| __timestamp | MiMedx Group, Inc. | Xenon Pharmaceuticals Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 12665000 | 5903000 |
| Thursday, January 1, 2015 | 20202000 | 2762000 |
| Friday, January 1, 2016 | 32407000 | 1114000 |
| Sunday, January 1, 2017 | 35219000 | 25573000 |
| Monday, January 1, 2018 | 36386000 | 6000000 |
| Tuesday, January 1, 2019 | 43081000 | 38845000 |
| Wednesday, January 1, 2020 | 39330000 | 50523000 |
| Friday, January 1, 2021 | 43283000 | 75463000 |
| Saturday, January 1, 2022 | 48316000 | 105767000 |
| Sunday, January 1, 2023 | 54634000 | 167512000 |
Infusing magic into the data realm
In the competitive landscape of pharmaceuticals, cost efficiency is paramount. Over the past decade, Xenon Pharmaceuticals Inc. and MiMedx Group, Inc. have showcased contrasting trajectories in their cost of revenue. From 2014 to 2023, MiMedx Group's cost of revenue grew steadily, peaking at approximately 54.6 million in 2023, marking a 331% increase from 2014. In contrast, Xenon Pharmaceuticals experienced a dramatic surge, with costs skyrocketing by over 2,700% during the same period, reaching around 167.5 million in 2023. This stark difference highlights Xenon's aggressive expansion and investment in research and development. As the industry evolves, understanding these financial dynamics offers valuable insights into strategic decision-making and operational efficiency.
Cost of Revenue Comparison: Biogen Inc. vs Xenon Pharmaceuticals Inc.
Viatris Inc. vs MiMedx Group, Inc.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Bio-Techne Corporation and Xenon Pharmaceuticals Inc.
Cost Insights: Breaking Down BioMarin Pharmaceutical Inc. and Xenon Pharmaceuticals Inc.'s Expenses
Comparing Cost of Revenue Efficiency: BioMarin Pharmaceutical Inc. vs MiMedx Group, Inc.
Walgreens Boots Alliance, Inc. vs Xenon Pharmaceuticals Inc.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Halozyme Therapeutics, Inc. vs MiMedx Group, Inc.
Analyzing Cost of Revenue: Pharming Group N.V. and MiMedx Group, Inc.
Cost of Revenue Comparison: Cytokinetics, Incorporated vs MiMedx Group, Inc.
Cost of Revenue Comparison: Ionis Pharmaceuticals, Inc. vs MiMedx Group, Inc.
Cost of Revenue Trends: Amneal Pharmaceuticals, Inc. vs Xenon Pharmaceuticals Inc.
Comparing SG&A Expenses: Xenon Pharmaceuticals Inc. vs MiMedx Group, Inc. Trends and Insights